BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Free Report) dropped 4.6% on Wednesday . The stock traded as low as $0.75 and last traded at $0.87. Approximately 37,797 shares traded hands during trading, an increase of 59% from the average daily volume of 23,730 shares. The stock had previously closed at $0.91.
BriaCell Therapeutics Trading Down 4.6 %
The firm’s fifty day moving average price is $1.29 and its two-hundred day moving average price is $1.56.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.
See Also
- Five stocks we like better than BriaCell Therapeutics
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- AMD is Down 35%. Now is the Time to Buy the Dip
- Why is the Ex-Dividend Date Significant to Investors?
- Amazon Stands Tall: New Highs Are in Sight
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
